应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02500 启明医疗-B
未开盘 07-08 16:08:17
1.600
-0.020
-1.23%
最高
1.800
最低
1.600
成交量
162.05万
今开
1.620
昨收
1.620
日振幅
12.35%
总市值
7.06亿
流通市值
7.06亿
总股本
4.41亿
成交额
268.78万
换手率
0.37%
流通股本
4.41亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
启明医疗-B6月股份变动月报表:股本维持稳定
公告速递 · 07-06 17:36
启明医疗-B6月股份变动月报表:股本维持稳定
启明医疗-B(02500):发行可转换债券的认购协议失效
智通财经 · 07-06 06:46
启明医疗-B(02500):发行可转换债券的认购协议失效
启明医疗-B午前大涨逾32% 公司与三方订立投资条款清单
新浪港股 · 07-03
启明医疗-B午前大涨逾32% 公司与三方订立投资条款清单
启明医疗:将获杭州高新及杭州盈智勤5亿元投资
财中社 · 07-02
启明医疗:将获杭州高新及杭州盈智勤5亿元投资
启明医疗-B(02500.HK)、杭州高新及杭州盈智勤订立投资条款清单
智通财经 · 07-02
启明医疗-B(02500.HK)、杭州高新及杭州盈智勤订立投资条款清单
杭州启明医疗获杭州高新、杭州盈智勤最高5亿元投资
美股速递 · 07-02
杭州启明医疗获杭州高新、杭州盈智勤最高5亿元投资
启明医疗-B5月无新增发行或股份变动
公告速递 · 06-03
启明医疗-B5月无新增发行或股份变动
启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成
公告速递 · 06-03
启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成
香港联交所:对启明医疗-B(02500)前公司秘书采取纪律行动
智通财经 · 05-19
香港联交所:对启明医疗-B(02500)前公司秘书采取纪律行动
启明医疗-B(02500):马力乔辞任执行董事
智通财经 · 05-15
启明医疗-B(02500):马力乔辞任执行董事
启明医疗-B(02500.HK):黄伟超辞任公司秘书
中金财经 · 05-06
启明医疗-B(02500.HK):黄伟超辞任公司秘书
启明医疗-B(02500)委任叶翠媚为公司秘书及授权代表
智通财经网 · 05-06
启明医疗-B(02500)委任叶翠媚为公司秘书及授权代表
启明医疗-B4月股份变动月报表,股本维持稳定
公告速递 · 05-06
启明医疗-B4月股份变动月报表,股本维持稳定
启明医疗-B2025年收入3.07亿元 亏损大幅收窄至4.08亿元 海外业务占比提升至32.05%
公告速递 · 04-29
启明医疗-B2025年收入3.07亿元 亏损大幅收窄至4.08亿元 海外业务占比提升至32.05%
启明医疗-B2026年3月无新增发行或股份变动
公告速递 · 04-08
启明医疗-B2026年3月无新增发行或股份变动
启明医疗-B(02500)发布年度业绩 股东应占亏损4.08亿元 同比收窄42.9%
智通财经 · 03-31
启明医疗-B(02500)发布年度业绩 股东应占亏损4.08亿元 同比收窄42.9%
启明医疗-B(02500.HK)拟3月31日举行董事会会议审批全年业绩
中金财经 · 03-19
启明医疗-B(02500.HK)拟3月31日举行董事会会议审批全年业绩
启明医疗-B盘中异动 下午盘股价大涨5.22%报2.420港元
市场透视 · 03-10
启明医疗-B盘中异动 下午盘股价大涨5.22%报2.420港元
启明医疗-B盘中异动 早盘股价大跌7.98%
市场透视 · 03-09
启明医疗-B盘中异动 早盘股价大跌7.98%
启明医疗-B03月06日主力净流出74.4万元 散户资金买入
市场透视 · 03-06
启明医疗-B03月06日主力净流出74.4万元 散户资金买入
加载更多
公司概况
公司名称:
启明医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
杭州启明医疗器械股份有限公司是一家主要从事生物心脏瓣膜的研发以及生产及销售从事生物心脏瓣膜的研发以及生产及销售的中国公司。该公司主要从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售。该公司的产品线已覆盖针对主动脉瓣、肺动脉瓣、二尖瓣、三尖瓣等心脏瓣膜类疾病介入治疗系列器械、肥厚型心肌病介入治疗的射频消融系统、高血介入治疗的肾动脉去交感神经超声消融系统以及其它手术配套耗材等。该公司的主要产品包括VenusA-Valve系統,VenusA-Plus系統,VenusA-Pilot系統,VenusP-Valve系統,TMVR 瓣膜, TTVR 瓣膜,瓣膜成形术球囊V8/TAV8及TriGUARD3脑栓塞保护仪器。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02500","market":"HK","secType":"STK","nameCN":"启明医疗-B","latestPrice":1.6,"timestamp":1783498097812,"preClose":1.62,"halted":0,"volume":1620500,"delay":0,"changeRate":-0.012345679012345689,"floatShares":441010235,"shares":441011443,"eps":-0.93,"marketStatus":"未开盘","change":-0.02,"latestTime":"07-08 16:08:17","open":1.62,"high":1.8,"low":1.6,"amount":2687795,"amplitude":0.123457,"askPrice":1.62,"askSize":500,"bidPrice":1.6,"bidSize":36500,"shortable":0,"etf":0,"ttmEps":-1.036052,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":0,"adr":0,"listingDate":1575907200000,"exchange":"SEHK","adjPreClose":1.62,"openAndCloseTimeList":[[1783474200000,1783483200000],[1783486800000,1783497600000]],"volumeRatio":0.578502,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02500","defaultTab":"news","newsList":[{"id":"1163817568","title":"启明医疗-B6月股份变动月报表:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163817568","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163817568?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:36","pubTimestamp":1783330581,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年7月6日公布2026年6月股份变动月报表。报告期为2026年6月,本月内公司股本结构整体保持稳定。报告显示,启明医疗-B于香港联交所上市的H股普通股数量在6月底为441,010,235股,与上月底一致;非上市外资股则维持1,208股不变。公司确认,其H股已符合香港联交所规定的最低公众持股量要求。公司在公告中表示,将继续严格遵守香港联交所《上市规则》及相关法律法规的要求。本份月报由执行董事柳美荣签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649119596","title":"启明医疗-B(02500):发行可转换债券的认购协议失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2649119596","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649119596?lang=zh_cn&edition=full","pubTime":"2026-07-06 06:46","pubTimestamp":1783291603,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启明医疗-B 发布公告,根据认购协议(经修订),倘先决条件未于截止日期或之前或认购人与公司可能商定的较后日期达成,则认购协议将失效及无效。根据框架协议,认购人已向公司支付过渡性贷款人民币1.5亿元。根据投资条款清单,于股东批准正式交易文件及其项下交易后30个工作日内,须完成认购总投资额为人民币3.5亿元并由公司发行的新股份及╱或新可转换债券。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02500","CVRT","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648586646","title":"启明医疗-B午前大涨逾32% 公司与三方订立投资条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2648586646","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648586646?lang=zh_cn&edition=full","pubTime":"2026-07-03 11:52","pubTimestamp":1783050720,"startTime":"0","endTime":"0","summary":" 启明医疗-B午前涨超31%,截至发稿,股价上涨31.85%,现报1.78港元,成交额909.53万港元。 启明医疗-B发布公告,于2026年7月1日,本公司、杭州高新及杭州盈智勤订立投资条款清单,据此,杭州高新及杭州盈智勤表示有意与其他潜在投资者透过潜在交易共同对本公司进行投资,总投资额最高达人民币5亿元。新可转换债券转换价为紧接正式交易文件签署前最后20个连续交易日在联交所所报股份的收市价的平均价格的110%,但转换价不超过每股2.5港元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifnxny5632898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","02500","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578112","title":"启明医疗:将获杭州高新及杭州盈智勤5亿元投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578112","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648578112?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:27","pubTimestamp":1782955620,"startTime":"0","endTime":"0","summary":"7月2日,启明医疗(02500)发布公告,公司、杭州高新及杭州盈智勤订立投资条款清单,据此,杭州高新及杭州盈智勤表示有意与其他潜在投资者通过潜在交易(包括股份认购及可转换债券认购)共同对公司进行投资,总投资额最高达5亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023791172754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["300478","BK1583","BK0028","02500","BK1574","BK0220","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648522329","title":"启明医疗-B(02500.HK)、杭州高新及杭州盈智勤订立投资条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2648522329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648522329?lang=zh_cn&edition=full","pubTime":"2026-07-02 07:09","pubTimestamp":1782947384,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","BK1574","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128132346","title":"杭州启明医疗获杭州高新、杭州盈智勤最高5亿元投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1128132346","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128132346?lang=zh_cn&edition=full","pubTime":"2026-07-02 06:06","pubTimestamp":1782943608,"startTime":"0","endTime":"0","summary":"杭州启明医疗有望获得来自杭州高新及杭州盈智勤的股权投资,总额最高可达人民币5亿元。此次投资计划彰显了投资方对该公司未来发展前景的信心与支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","BK1100","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184585182","title":"启明医疗-B5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1184585182","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184585182?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:51","pubTimestamp":1780480269,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年6月3日发布截至2026年5月31日的股份变动月报表。公告显示,公司法定注册股本为人民币441,011,443元,其中包括441,010,235股H股及1,208股非上市外资股,面值均为人民币1元。相比上月底,5月内上述股本数量无增减。公告披露,截至5月末,公司已发行的H股为441,010,235股,未有任何新增发行或库存股份变化;非上市外资股为1,208股,也未有变动。公司确认符合香港联交所对于H股的公众持股要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150022016","title":"启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1150022016","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150022016?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:37","pubTimestamp":1780475861,"startTime":"0","endTime":"0","summary":"启明医疗-B宣布,已于最新公告中提呈授予董事会一般性授权,可在2026年6月25日股东大会批准后,于授权有效期内酌情购回不超过已发行及尚未购回H股总数10%的股份。于公告披露前的最后实际可行日期,该公司已发行及尚未购回的股份总数为441,011,443股,其中H股为441,010,235股,这意味着若获授权通过,购回规模最高可达44,101,023股。公司目前尚未持有任何库存股份,亦无接获核心关连人士向公司出售股份的通知。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636683193","title":"香港联交所:对启明医疗-B(02500)前公司秘书采取纪律行动","url":"https://stock-news.laohu8.com/highlight/detail?id=2636683193","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636683193?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:00","pubTimestamp":1779181236,"startTime":"0","endTime":"0","summary":"智通财经AP配货西,5月19日,香港联交所发文,谴责启明医疗-B前公司秘书黄伟超并进一步指令黄伟超须完成培训。香港联交所提到,启明医疗披露其于2020年1月至2023年6月期间,在未经授权的情况下向两名执行董事提供约24.77亿元人民币的财务资助,并承认违反《上市规则》第十三、十四及十四A章有关汇报、公告、通函及独立股东批准的规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02500","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089738","title":"启明医疗-B(02500):马力乔辞任执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089738","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635089738?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:38","pubTimestamp":1778845111,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启明医疗-B(02500)发布公告,马力乔先生因其他个人事务已于2026年5月15日提请辞任执行董事,自2026年5月15日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02500","BK1583","BK1574","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633189530","title":"启明医疗-B(02500.HK):黄伟超辞任公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633189530","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633189530?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:17","pubTimestamp":1778062623,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨启明医疗-B(02500.HK)宣布,黄伟超已提呈辞任(i)公司公司秘书;(ii)香港联合交易所有限公司证券上市规则第3.05条项下公司的授权代表;及(iii)根据上市规则第19A.13(2)条及香港法例第622章公司条例第16部的规定代公司在香港接收法律程序文件及通知书的授权代表,自2026年5月6日起生效。\r\n\r\n 叶翠媚已获委任为公司秘书及授权代表,自2026年5月6日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260506/32203269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","BK1583","02500","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633185941","title":"启明医疗-B(02500)委任叶翠媚为公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185941","media":"智通财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633185941?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:56","pubTimestamp":1778061415,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启明医疗-B(02500)公布,黄伟超先生已辞任该公司的公司秘书及授权代表,叶翠媚女士已获委任为公司秘书及授权代表,自2026年5月6日起生效。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1100","BK1574","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139453711","title":"启明医疗-B4月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1139453711","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139453711?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:42","pubTimestamp":1778060548,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年5月6日披露截至2026年4月30日止的股份变动月报表。根据公告,本月内公司各类股份总数及已发行股份数均保持不变,股本结构整体稳定。在关于期权与激励计划方面,公司披露其股份期权计划下可行使的期权总数为44,101,023股,但截至本月无新授出或行使的期权,相关股份并未发生变动。此月报表由该公司执行董事柳美荣签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180708974","title":"启明医疗-B2025年收入3.07亿元 亏损大幅收窄至4.08亿元 海外业务占比提升至32.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180708974","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180708974?lang=zh_cn&edition=full","pubTime":"2026-04-29 16:40","pubTimestamp":1777452023,"startTime":"0","endTime":"0","summary":"报告期内,公司聚焦经导管心脑血管产品的临床试验与上市进程,通过费用管控、组织升级与销售模式优化,逐步提升经营效率和盈利能力。根据年报披露,2025年公司实现收入人民币3.07亿元,较2024年度的4.71亿元下降34.86%。其中海外收入录得人民币9,830万元,同比增长19.17%,收入占比升至32.05%。成本及费用方面,销售及分销开支同比减少20.23%至人民币1.95亿元,研究开发成本为人民币2.67亿元,同比下降21.62%,行政开支则下降33.74%至人民币9,676万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"启明医疗-B2025年收入3.07亿元 亏损大幅收窄至4.08亿元 海外业务占比提升至32.05%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144115255","title":"启明医疗-B2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1144115255","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144115255?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:35","pubTimestamp":1775637336,"startTime":"0","endTime":"0","summary":"2026年4月8日,杭州启明医疗器械股份有限公司发布截至2026年3月31日的股份变动月报表。报告显示,公司本月已发行及注册股本未发生变化,其中普通股H股441,010,235股,非上市外资股1,208股,合计441,011,443股。本月内无新增发行或回购注销活动。此前于2021年12月8日、17日及20日合计购回的3,114,000股H股仍处于待注销状态,未对当期已发行股份总数造成影响。本次月报由公司执行董事柳美荣签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581976","title":"启明医疗-B(02500)发布年度业绩 股东应占亏损4.08亿元 同比收窄42.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581976","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623581976?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:38","pubTimestamp":1774960690,"startTime":"0","endTime":"0","summary":"智通财经APP讯,启明医疗-B 发布截至2025年12月31日止年度业绩,该集团取得收益3.07亿元,同比减少34.8%;母公司拥有人应占亏损4.08亿元,同比收窄42.9%;每股基本亏损0.93元。公告称,于报告期,我们全部收益均由销售医疗器械产生。TPVR产品VenusP-Valve于2022年4月8日获欧盟CE MDR 认证,并于2022年7月11日获NMPA批准上市,自商业化以来,构成我们海外收入的主要部分。收入波动是由于面对国内竞争激烈的市场环境,产品单价和销售量均有一定程度下降所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423267.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1100","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620242754","title":"启明医疗-B(02500.HK)拟3月31日举行董事会会议审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620242754","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620242754?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:37","pubTimestamp":1773920222,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨启明医疗-B(02500.HK)公告,谨定于2026年3月31日(星期二)举行董事会会议,以审议及批准公司及其附属公司截至2025年12月31日止年度之全年业绩及其发布,以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32081950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","BK1100","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618095336","title":"启明医疗-B盘中异动 下午盘股价大涨5.22%报2.420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618095336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618095336?lang=zh_cn&edition=full","pubTime":"2026-03-10 14:48","pubTimestamp":1773125334,"startTime":"0","endTime":"0","summary":"2026年03月10日下午盘14时48分,启明医疗-B股票出现异动,股价快速拉升5.22%。截至发稿,该股报2.420港元/股,成交量120.35万股,换手率0.27%,振幅6.09%。资金方面,该股资金流入127.361万港元,流出125.165万港元。启明医疗-B股票所在的医疗设备及用品行业中,整体涨幅为0.35%。其相关个股中,紫元元、先瑞达医疗-B、归创通桥涨幅较大,振幅较大的相关个股有紫元元、京玖康疗、普华和顺,振幅分别为45.45%、11.67%、11.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031014485495469eec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031014485495469eec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1100","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618760329","title":"启明医疗-B盘中异动 早盘股价大跌7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618760329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618760329?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:32","pubTimestamp":1773019932,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时32分,启明医疗-B股票出现波动,股价快速跳水7.98%。截至发稿,该股报2.190港元/股,成交量55.95万股,换手率0.13%,振幅6.72%。启明医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.63%。其相关个股中,智云健康、健世科技-B、加和国际控股涨幅较大,振幅较大的相关个股有健世科技-B、启明医疗-B、微创心通-B,振幅分别为7.06%、6.72%、5.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909321297aa99c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030909321297aa99c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02500","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617632875","title":"启明医疗-B03月06日主力净流出74.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2617632875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617632875?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784950,"startTime":"0","endTime":"0","summary":"03月06日, 启明医疗-B股价跌2.06%,报收2.38元,成交金额388.3万元,换手率0.37%,振幅4.12%,量比1.33。启明医疗-B今日主力资金净流出74.4万元,上一交易日主力净流入37.4万元。该股近5个交易日下跌13.77%,主力资金累计净流出121.4万元;近20日主力资金累计净流出117.5万元,其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162012a4534c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306162012a4534c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02500","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.venusmedtech.com","stockEarnings":[{"period":"1week","weight":0.3008},{"period":"1month","weight":0.3675},{"period":"3month","weight":-0.2233},{"period":"6month","weight":-0.3676},{"period":"1year","weight":-0.3774},{"period":"ytd","weight":-0.3277}],"compareEarnings":[{"period":"1week","weight":0.0576},{"period":"1month","weight":-0.0186},{"period":"3month","weight":-0.0603},{"period":"6month","weight":-0.0775},{"period":"1year","weight":0.0021},{"period":"ytd","weight":-0.0558}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州启明医疗器械股份有限公司是一家主要从事生物心脏瓣膜的研发以及生产及销售从事生物心脏瓣膜的研发以及生产及销售的中国公司。该公司主要从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售。该公司的产品线已覆盖针对主动脉瓣、肺动脉瓣、二尖瓣、三尖瓣等心脏瓣膜类疾病介入治疗系列器械、肥厚型心肌病介入治疗的射频消融系统、高血介入治疗的肾动脉去交感神经超声消融系统以及其它手术配套耗材等。该公司的主要产品包括VenusA-Valve系統,VenusA-Plus系統,VenusA-Pilot系統,VenusP-Valve系統,TMVR 瓣膜, TTVR 瓣膜,瓣膜成形术球囊V8/TAV8及TriGUARD3脑栓塞保护仪器。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.070986},{"month":2,"riseRate":0.2,"avgChangeRate":-0.071618},{"month":3,"riseRate":0,"avgChangeRate":-0.254926},{"month":4,"riseRate":0.666667,"avgChangeRate":0.054263},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.128903},{"month":6,"riseRate":0.666667,"avgChangeRate":0.098187},{"month":7,"riseRate":0.5,"avgChangeRate":0.056413},{"month":8,"riseRate":0.2,"avgChangeRate":-0.115597},{"month":9,"riseRate":0.4,"avgChangeRate":-0.03911},{"month":10,"riseRate":0.2,"avgChangeRate":-0.074139},{"month":11,"riseRate":0.6,"avgChangeRate":0.100743},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006043}],"exchange":"SEHK","name":"启明医疗-B","nameEN":"VENUS MEDTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"启明医疗-B(02500)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供启明医疗-B(02500)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"启明医疗-B,02500,启明医疗-B股票,启明医疗-B股票老虎,启明医疗-B股票老虎国际,启明医疗-B行情,启明医疗-B股票行情,启明医疗-B股价,启明医疗-B股市,启明医疗-B股票价格,启明医疗-B股票交易,启明医疗-B股票购买,启明医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"启明医疗-B(02500)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供启明医疗-B(02500)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}